INTAI Technology Corporation

TPEX:4163 Stock Report

Mkt Cap: NT$5.3b

We’ve recently updated our valuation analysis.

INTAI Technology Valuation

Is 4163 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4163?

Other financial metrics that can be useful for relative valuation.

4163 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.5x
Enterprise Value/EBITDA13.5x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 4163's PE Ratio compare to its peers?

The above table shows the PE ratio for 4163 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average29.5x
4737 Bionime
6762 Delta Asia International
1733 Apex Biotechnology
4106 Wellell
4163 INTAI Technology

Price-To-Earnings vs Peers: 4163 is good value based on its Price-To-Earnings Ratio (12x) compared to the peer average (29.5x).

Price to Earnings Ratio vs Industry

How does 4163's PE Ratio compare vs other companies in the TW Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a-0.4%

Price-To-Earnings vs Industry: 4163 is good value based on its Price-To-Earnings Ratio (12x) compared to the TW Medical Equipment industry average (18.5x)

Price to Earnings Ratio vs Fair Ratio

What is 4163's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4163 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio12x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4163's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of 4163 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4163 (NT$109.5) is trading below our estimate of fair value (NT$236.33)

Significantly Below Fair Value: 4163 is trading below fair value by more than 20%.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies